Last updated on April 20, 2014 at 17:20 EDT

Aeterna Zentaris to Present at 7th Annual JMP Securities Healthcare Conference in New York

July 5, 2012

QUÉBEC CITY, July 5, 2012 /PRNewswire/ – Aeterna Zentaris Inc. (NASDAQ:
AEZS) (TSX: AEZ) (the ”Company”) today announced that its President and
CEO, Juergen Engel, PhD, will be presenting a corporate overview at the
7(th) Annual JMP Securities Healthcare Conference on Thursday, July 12, 2012,
at 10:30 am (Eastern), in the Gramercy South Room of the Peninsula
Hotel in New York City.

A live webcast of this presentation will be available on Aeterna
Zentaris’ website at www.aezsinc.com, in the Newsroom section. A replay of the webcast will also be
available on the Company’s website for a period of 90 days.

About Aeterna Zentaris

Aeterna Zentaris is an oncology and endocrinology drug development
company currently investigating treatments for various unmet medical
needs. The Company’s pipeline encompasses compounds at all stages of
development, from drug discovery through to marketed products. For more
information please visit www.aezsinc.com.


Source: PR Newswire